Health TrialsbyHealthPanel

Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)

ConditionsBreast CancerMetastatic Breast CancerRadiation Therapy Complication
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age19-100
SponsorSamsung Medical Center

About this trial

This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

histologically confirmed breast cancer

presence of distant metastasis

radiation therapy using IMRT, SBRT, or proton therapy is done or planned

Able and willing to comply with the study protocol

Disqualifiers

unable to adhere to the study protocol

Trial population

Women treated with hypofractionated RT using IMRT, SBRT, or proton therapy for metastatic breast cancer

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Local control rate

LC after radiation therapy

Time frame
1-year

Secondary outcomes

1

Overall survival rate

Time frame
1-year
2

Disease-free survival

disease-free survival rate after the time of RT

Time frame
1-year
3

Treatment-related toxicities

Acute and chronic radiation toxicities according to CTCAE v5.0

Time frame
1-year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Samsung Medical Center

Lead sponsor

Source ClinicalTrials.gov
Apply now